Your browser doesn't support javascript.
loading
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine, Shigeki; Kiyono, Tohru; Ryo, Eijitsu; Ogawa, Reiko; Wakai, Susumu; Ichikawa, Hitoshi; Suzuki, Koyu; Arai, Satoru; Tsuta, Koji; Ishida, Mitsuaki; Sasajima, Yuko; Goshima, Naoki; Yamazaki, Naoya; Mori, Taisuke.
Affiliation
  • Sekine S; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Kiyono T; Division of Molecular Pathology.
  • Ryo E; Division of Carcinogenesis and Cancer Prevention.
  • Ogawa R; Department of Cell Culture Technology, and.
  • Wakai S; Division of Molecular Pathology.
  • Ichikawa H; Division of Molecular Pathology.
  • Suzuki K; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Arai S; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Tsuta K; Department of Pathology and.
  • Ishida M; Department of Dermatology, St. Luke's International Hospital, Tokyo, Japan.
  • Sasajima Y; Department of Pathology and Laboratory Medicine, Kansai Medical University, Osaka, Japan.
  • Goshima N; Department of Pathology and Laboratory Medicine, Kansai Medical University, Osaka, Japan.
  • Yamazaki N; Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan.
  • Mori T; Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tokyo, Japan.
J Clin Invest ; 129(9): 3827-3832, 2019 05 30.
Article in En | MEDLINE | ID: mdl-31145701
ABSTRACT
Poroma is a benign skin tumor exhibiting terminal sweat gland duct differentiation. The present study aimed to explore the potential role of gene fusions in the tumorigenesis of poromas. RNA sequencing and reverse transcription PCR identified highly recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poromas (92/104 lesions, 88.5%) and their rare malignant counterpart, porocarcinomas (7/11 lesions, 63.6%). A WWTR1-NUTM1 fusion was identified in a single lesion of poroma. Fluorescent in-situ hybridization confirmed genomic rearrangements involving these genetic loci. Immunohistochemical staining could readily identify the YAP1 fusion products as nuclear expression of the N-terminal portion of YAP1 with a lack of the C-terminal portion. YAP1 and WWTR1, also known as YAP and TAZ, respectively, encode paralogous transcriptional activators of TEAD, which are negatively regulated by the Hippo signaling pathway. The YAP1 and WWTR1 fusions strongly transactivated a TEAD reporter and promoted anchorage-independent growth, confirming their tumorigenic roles. Our results demonstrate the frequent presence of transforming YAP1 fusions in poromas and porocarcinomas and suggest YAP1/TEAD-dependent transcription as a candidate therapeutic target against porocarcinoma.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sweat Gland Neoplasms / Transcription Factors / Nuclear Proteins / Carcinoma / Trans-Activators / Adaptor Proteins, Signal Transducing / Poroma / Neoplasm Proteins Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: J Clin Invest Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sweat Gland Neoplasms / Transcription Factors / Nuclear Proteins / Carcinoma / Trans-Activators / Adaptor Proteins, Signal Transducing / Poroma / Neoplasm Proteins Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: J Clin Invest Year: 2019 Document type: Article Affiliation country: